(Q54517905)
Statements
HER-3 status by immunohistochemistry in HER-2-positive metastatic breast cancer patients treated with trastuzumab: correlation with clinical outcome (English)
Jennifer Foglietta
Maria Grazia Mameli
Lucia Stocchi
Daniela Fenocchio
Paola Anastasi
Carlo Basurto
Verena De Angelis